Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia.
Authors: Galiazzo Giorgia, De Silva Margherita, Giancola Fiorella, Rinnovati Riccardo, Peli Angelo, Chiocchetti Roberto
Journal: Equine veterinary journal
Summary
# Editorial Summary Cannabidiol and related compounds show promise for pain management through multiple receptor pathways, yet their neurobiological targets in horses remain poorly characterised. Galiazzo and colleagues mapped the distribution of four key cannabinoid-related receptors—TRPV1, PPAR-gamma, GPR55 and GPR3—within equine cervical dorsal root ganglia using immunohistochemical techniques, identifying which neuronal populations express these receptors and their localisation within sensory nerve cell bodies and fibres. The researchers found differential expression patterns across receptor types, with TRPV1 showing particularly robust labelling in nociceptive neurons, whilst GPR55 and GPR3 demonstrated more selective cellular distribution, indicating that cannabinoid signalling in equine pain pathways operates through multiple, anatomically distinct mechanisms. Understanding precisely where these receptors sit within the dorsal root ganglia—critical relay stations for pain transmission to the spinal cord—provides a mechanistic foundation for evaluating whether CBD and other cannabinoid compounds might genuinely modulate nociception in horses, rather than relying on anecdotal reports. For practitioners considering cannabinoid-based interventions for pain, lameness or inflammatory conditions, this anatomical framework suggests the pharmacology is genuinely present in equine nervous tissue, though clinical efficacy and optimal dosing protocols remain areas requiring rigorous investigation.
Read the full abstract on PubMed
Practical Takeaways
- •CBD and other cannabinoids may have therapeutic potential for pain management in horses through multiple receptor mechanisms, warranting further clinical investigation
- •Current understanding of cannabinoid receptor distribution in equine nervous tissue is limited; more research is needed before clinical recommendations can be made
- •These findings provide anatomical basis for why cannabinoid-based treatments might affect equine pain perception, but clinical efficacy and safety data are still lacking
Key Findings
- •TRPV1, PPAR-gamma, GPR55 and GPR3 receptors are distributed in equine cervical dorsal root ganglia, representing potential targets for cannabinoid-based therapeutic interventions
- •Cannabidiol (CBD) acts on multiple cannabinoid and cannabinoid-related receptors that have been understudied in veterinary and equine medicine
- •These receptors may mediate beneficial effects on pain perception through endogenous, plant-derived or synthetic cannabinoid activation